7.45% Less UROLOGIX INC (OTCMKTS:ULGX) Shorted Shares

June 27, 2018 - By Matthew Medley

Big Money Sentiment decreased to 0 in Q1 2018. It has change of Infinity, from 2017Q4’s Infinity. The ratio dived due to Urologix, Inc. positioning: 0 sold and 0 reduced. 0 funds bought positions and 0 increased positions. Investors holded 60,521 in 2017Q4 but now own 60,521 shares or 0.00% without change.
Gemmer Asset Management Ltd Llc owns 40,521 shs for 0% of their capital. Mairs & Power Inc has invested 0% in Urologix, Inc. (OTCMKTS:ULGX).

Change of 7.45% for UROLOGIX INC (OTCMKTS:ULGX)’s shares shorted was showed. It was announced in June by FINRA the 38,500 shares shorted on ULGX. The down change of 7.45% from 41,600 shares was reported. UROLOGIX INC (OTCMKTS:ULGX) has 286,700 shares average volume. It’ll cost 0 days for ULGX to restore its previous position.

ULGX is hitting $0.07311 during the last trading session, after increased 4.44%.Currently Urologix, Inc. is after 0.00% change in last June 27, 2017. ULGX has 134,846 shares volume. ULGX underperformed by 12.57% the S&P 500.

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia in the United States.The firm is worth $1.56 million. The firm offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort.Last it reported negative earnings. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.